New clinical, endoscopic, and imaging modalities for diagnosing varices and predicting bleeding are being investigated. Transnasal endoscopy and ultrathin battery-powered esophagoscopes are being used to improve patient comfort and compliance. Patients who respond to portal pressure-reducing drugs not only have a reduced risk of bleeding, but also a reduced risk of developing other complications, with improved survival. Nitrates have been shown to have no definite role in primary prophylaxis against variceal bleeding. The hemodynamic response to treatment has an independent prognostic value for the risk of variceal bleeding. Newer drugs have been investigated for reducing the hepatic venous pressure gradient, but with little success. Survival after bleeding has increased due to improved patient care and technological advances. Combined radiographic and endoscopic management of gastric varices is evolving and appears to be promising. Nonvariceal bleeding from portal hypertensive gastropathy is increasingly being recognized as a potential cause of bleeding in patients with portal hypertension, and pharmacotherapy with octreotide appears to be promising for the treatment of this condition. Variceal band ligation in children has been found to be as safe and effective as in adults.
References
1
Giannini E, Botta F, Borro P. et al .
Platelet count/spleen diameter ratio: proposal and validation of a noninvasive parameter to predict the presence of esophageal varices in patients with liver cirrhosis.
Gut.
2003;
52
1200-1205
2
Thomopoulos K C, Labropoulou-Karatza C, Mimidis K P. et al .
Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis.
Dig Liver Dis.
2003;
35
473-478
3
Saeian K, Staff D, Knox J. et al .
Unsedated transnasal endoscopy: a new technique for accurately detecting and grading esophageal varices in cirrhotic patients.
Am J Gastroenterol.
2002;
97
2246-2249
4
Madhotra R, Mokhashi M, Willner I. et al .
Prospective evaluation of a 3.1-mm battery-powered esophagoscope in screening for esophageal varices in cirrhotic patients.
Am J Gastroenterol.
2003;
98
807-812
5
Nakayama Y, Imuta M, Funama Y. et al .
CT portography by multidetector helical CT: comparison of three rendering models.
Radiat Med.
2002;
20
273-279
6
Matsuo M, Kanematsu M, Kim T. et al .
Esophageal varices: diagnosis with gadolinium-enhanced MR imaging of the liver for patients with chronic liver damage.
AJR Am J Roentgenol.
2003;
180
461-466
7
Sato T, Yamazaki K, Toyota J. et al .
Color Doppler findings of gastric varices compared with findings on computed tomography.
J Gastroenterol.
2002;
37
604-610
8
Pontes J M, Leitao M C, Portela F. et al .
Endosonographic Doppler-guided manometry of esophageal varices: experimental validation and clinical feasibility.
Endoscopy.
2002;
34
966-972
9
Miller L, Banson F L, Bazir K. et al .
Risk of esophageal variceal bleeding based on endoscopic ultrasound evaluation of the sum of esophageal variceal cross-sectional surface area.
Am J Gastroenterol.
2003;
98
454-459
11
Choi Y J, Baik S K, Park D H. et al .
Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis.
J Gastroenterol Hepatol.
2003;
18
424-429
12
Abraldes J G, Tarantino I, Turnes J. et al .
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Hepatology.
2003;
37
902-908
13
Bureau C, Peron J M, Alric L. et al .
”A la carte” treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding.
Hepatology.
2002;
36
1361-1366
14
Bellis L, Berzigotti A, Abraldes J G. et al .
Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
Hepatology.
2003;
37
378-384
15
Banares R, Moitinho E, Matilla A. et al .
Randomized comparison of long term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
Hepatology.
2002;
36
1367-1373
16
Venon W D, Baronio M, Leone N. et al .
Effects of long-term irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study.
J Hepatol.
2003;
38
455-460
17
De B K, Bandyopadhyay K, Das T K. et al .
Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
Am J Gastroenterol.
2003;
98
1371-1376
18
Escorsell A, Gines A, Llach J. et al .
Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices.
Hepatology.
2002;
36
936-940
19
Garcia Pagan J C, Morillas R, Banares R. et al .
Propranolol plus placebo versus propranolol plus isosorbide mononitrate in the prevention of a first variceal bleed: a double blind RCT.
Hepatology.
2003;
37
1260-1266
20
Borroni G, Salerno F, Cazzaniga M. et al .
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.
J Hepatol.
2002;
37
315-321
21
Abecasis R, Kravetz D, Fassio E. et al .
Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: a preliminary study.
Hepatology.
2003;
37
359-365
22
Spiegel B M, Targownik L, Dulai G S. et al .
Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective?.
Hepatology.
2003;
37
366-377
23
Arguedas M R, Heudebert G R, Eloubeidi M A. et al .
Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices.
Am J Gastroenterol.
2002;
97
2441-2452
24
D’Amico G, Pietrosi G, Tarantino I. et al .
Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis.
Gastroenterology.
2003;
124
1277-1291
25
Yol S, Belviranli M, Toprak S. et al .
Endoscopic clipping versus band ligation in the management of bleeding esophageal varices.
Surg Endosc.
2003;
17
38-42
26
D’Amico G, De Franchis R and a Cooperative study group.
Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators.
Hepatology.
2003;
38
599-612
27
Chalasani N, Kahi C, François F. et al .
Improved patient survival after acute variceal bleeding: a multicenter cohort study.
Am J Gastroenterol.
2003;
98
653-659
28
Evrard S, Dumonceau J M, Delhaye M. et al .
Endoscopic Histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial.
Endoscopy.
2003;
35
729-735
29
Merli M, Nicolini G, Angeloni S. et al .
Incidence and natural history of small esophageal varices in cirrhotic patients.
J Hepatol.
2003;
38
266-272
30
Taniai N, Onda M, Tajiri T. et al .
Combined endoscopic and radiologic intervention to treat esophageal varices.
Hepatogastroenterology.
2002;
49
984-988
33
Wu C Y, Yeh H Z, Chen G H.
Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis.
J Clin Gastroenterol.
2002;
35
127-132
34
Battaglia G, Bocus P, Morbin T. et al .
Endoscopic Doppler US-guided injection for gastric varices: case report.
Gastrointest Endosc.
2003;
57
608-611
36
Shiba M, Higuchi K, Nakamura K. et al .
Efficacy and safety of balloon-occluded endoscopic injection sclerotherapy as a prophylactic treatment for high-risk gastric fundal varices: a prospective, randomized, comparative clinical trial.
Gastrointest Endosc.
2002;
56
522-528
37
Miyamoto Y, Oho K, Kumamoto M. et al .
Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.
J Gastroenterol Hepatol.
2003;
18
934-942
38
Tripathi D, Therapondos G, Jackson E. et al .
The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations.
Gut.
2002;
51
270-274
39
Chu E C, Chick W, Hillebrand D J. et al .
Fatal spontaneous gallbladder variceal bleeding in a patient with alcoholic cirrhosis.
Dig Dis Sci.
2002;
47
2682-2685
40
Handschin A E, Weber M, Weishaupt D. et al .
Contrast-enhanced three-dimensional magnetic resonance angiography for visualization of ectopic varices.
Dis Colon Rectum.
2002;
45
1541-1544
41
Yoo H Y, Eustace J A, Verma S. et al .
Accuracy and reliability of the endoscopic classification of portal hypertensive gastropathy.
Gastrointest Endoscopy.
2002;
56
675-680
42
Zhou Y, Qiao L, Wu J. et al .
Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study.
J Gastroenterol Hepatol.
2002;
17
973-979
43
Bruha R, Marecek Z, Spicak J. et al .
Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding.
Hepatogastroenterology.
2002;
49
1161-1166
44
Shimizu T, Onda M, Tajiri T. et al .
Bleeding portal-hypertensive gastropathy managed successfully by partial splenic embolization.
Hepatogastroenterology.
2002;
49
947-949
46
Lorenz A, Stadtler N, Schulz H J.
Laser disintegration of cyanoacrylate clot with successful endoscopic removal of sclerotherapy needle from gastric varix.
Endoscopy.
2002;
34
670-672
48
Zargar S A, Javid G, Khan B A. et al .
Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction.
Hepatology.
2002;
36
666-672
49
Dowidar N, Hafez A.
Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis: a randomized controlled trial evaluating effect of sclerosant concentration.
J Egypt Soc Parasitol.
2002;
32
537-549
50
Avgerinos A, Viazis N, Armonis A. et al .
Early increase of lower oesophageal sphincter pressure after band ligation of oesophageal varices in cirrhotics: an intriguing phenomenon.
Eur J Gastroenterol Hepatol.
2002;
14
1319-1323
